Sanofi (SNY) Amortization - Intangibles (2009 - 2025)

Sanofi has disclosed Amortization - Intangibles across 17 years of filings, most recently posting $4.4 billion for Q4 2025.

• Amortization - Intangibles for Q4 2025 came in at $4.4 billion, up 25.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.1 billion (up 0.73% YoY), and the FY2025 annual result was $2.1 billion, up 10.61% from the prior year.
• Amortization - Intangibles came in at $4.4 billion for Q4 2025 at Sanofi, up from -$1.4 billion in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $4.4 billion in Q4 2025 to a low of -$1.8 billion in Q4 2021.
• The 5-year median for Amortization - Intangibles is -$465.6 million (2021), against an average of $21.0 million.
• Across the five-year window, Amortization - Intangibles soared 540.99% in 2023 and plunged 228.64% in 2025, its largest moves.
• Sanofi's Amortization - Intangibles stood at -$1.8 billion in 2021, then surged by 74.2% to -$466.3 million in 2022, then jumped by 540.99% to $2.1 billion in 2023, then soared by 70.93% to $3.5 billion in 2024, then rose by 25.56% to $4.4 billion in 2025.
• The last three Amortization - Intangibles figures came in at $4.4 billion (Q4 2025), -$1.4 billion (Q3 2025), and -$427.9 million (Q2 2025), per Business Quant data.